Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Congress
Main Content

Parallel Session 2404

Serendipity, Genius, and Perseverance in Movement Disorders: The Non-Linear Path to Discovery

Monday, August 28, 2023
15:00 – 17:00

 

In this session, the faculty will give insights into the discovery and implementation of these major treatment advances in movement disorders.

Chairs:
Beomseok Jeon, South Korea 
Raymond Rosales, Philippines

Neurology / Psychiatry Interface 

Santiago Perez Lloret, Argentina 

Botulinum Toxin: A Winding Path with Novel Application 
Cynthia Comella, USA 

Lesioning and Stimulation: How DBS Was Born 
Patricia Limousin, United Kingdom 

CSPC Liaison: 
Victor Fung, Australia

At the conclusion of this session, participants should be better able to:

  1. Discuss how observations of both spontaneous and drug-induced movement disorders in psychiatric patients have led to the understanding of and development of therapies for patients with movement disorders
  2. Describe how botulinum toxin was developed as a therapy from theory to bench to bedside in ophthalmology, and how its use was extended to movement disorders and other neurological and non-neurological disorders, shedding light on how considered off-label
  3. Discuss the role of anatomical knowledge, animal studies, and studying the effects of serendipitous pathological lesions in humans have contributed to the development and refinement of functional neurosurgery for movement disorders

Recommended Audience:
Clinician, Researcher / Basic Scientist, Health Professional (non-physician), Fellow / Resident / Student, Industry

Education Level:
Beginner/Foundational, Intermediate/Experienced, Advanced/Expert

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice